Provided is a composition for treating diabetes, including a hypoglycemic agent and a Yukmijihwang-tang extract. More particularly, the hypoglycemic agent is administered into an individual, and the Yukmijihwang-tang extract is administered into the individual, thereby considerably increasing a hypoglycemic effect of the hypoglycemic agent, and preventing and reducing various diabetic complications such as diabetes and diabetic liver damage, renal damage, hyperlipidemia immunosuppression and ocular damage.

Provided is a composition for treating diabetes, including a hypoglycemic agent and a Yukmijihwang-tang extract. More particularly, the hypoglycemic agent is administered into an individual, and the Yukmijihwang-tang extract is administered into the individual, thereby considerably increasing a hypoglycemic effect of the hypoglycemic agent, and preventing and reducing various diabetic complications such as diabetes and diabetic liver damage, renal damage, hyperlipidemia immunosuppression and ocular damage.

Provided is a composition for treating diabetes, including a hypoglycemic agent and a Yukmijihwang-tang extract. More particularly, the hypoglycemic agent is administered into an individual, and the Yukmijihwang-tang extract is administered into the individual, thereby considerably increasing a hypoglycemic effect of the hypoglycemic agent, and preventing and reducing various diabetic complications such as diabetes and diabetic liver damage, renal damage, hyperlipidemia immunosuppression and ocular damage.

The present invention provides a pharmaceutical composition and health functional food composition for preventing or treating female menopausal disease including extract of Ribes fasciculatum leaves as an active ingredient, and a pharmaceutical composition and health functional food composition for preventing or treating female menopausal disease including an extract of Cornus officinalis and extract of Ribes fasciculatum leaves as active ingredients.

The present invention provides a pharmaceutical composition and health functional food composition for preventing or treating female menopausal disease including extract of Ribes fasciculatum leaves as an active ingredient, and a pharmaceutical composition and health functional food composition for preventing or treating female menopausal disease including an extract of Cornus officinalis and extract of Ribes fasciculatum leaves as active ingredients.

The present invention provides a pharmaceutical composition and health functional food composition for preventing or treating female menopausal disease including extract of Ribes fasciculatum leaves as an active ingredient, and a pharmaceutical composition and health functional food composition for preventing or treating female menopausal disease including an extract of Cornus officinalis and extract of Ribes fasciculatum leaves as active ingredients.

Various embodiments of health supplements for mammals are disclosed. The health supplement consists of one or more metabolite ingestion components; anti-inflammatory components; and oral absorption components. The metabolite ingestion component includes green-lipped mussel powder in an amount between 1-5 mg/kg of body weight. The anti-inflammatory component includes cinnamon powder in an amount between 0.1-1. mg/kg of body weight; ascorbic acid powder; turmeric powder present in an amount between 0.1-1.0 mg/kg of body weight; Piper nigrum powder in an amount between 0.05-0.2 mg/kg of body weight; and the oral absorption component includes diatomaceous earth powder and molasses powder. The metabolite ingestion component includes sea cucumber powder, sodium hyaluronate powder, methylsylfonylmethane powder, and creatine monohydrate powder. The anti-inflammatory component includes Boswellia serrata powder, Harpagophytum procumbens powder, and calcined curcumin powder. The oral absorption component includes Lactobacillus probiotic powder; and calcined dolomite powder.

Various embodiments of health supplements for mammals are disclosed. The health supplement consists of one or more metabolite ingestion components; anti-inflammatory components; and oral absorption components. The metabolite ingestion component includes green-lipped mussel powder in an amount between 1-5 mg/kg of body weight. The anti-inflammatory component includes cinnamon powder in an amount between 0.1-1. mg/kg of body weight; ascorbic acid powder; turmeric powder present in an amount between 0.1-1.0 mg/kg of body weight; Piper nigrum powder in an amount between 0.05-0.2 mg/kg of body weight; and the oral absorption component includes diatomaceous earth powder and molasses powder. The metabolite ingestion component includes sea cucumber powder, sodium hyaluronate powder, methylsylfonylmethane powder, and creatine monohydrate powder. The anti-inflammatory component includes Boswellia serrata powder, Harpagophytum procumbens powder, and calcined curcumin powder. The oral absorption component includes Lactobacillus probiotic powder; and calcined dolomite powder.

The present invention provides a method of using a plant extract or active fraction thereof for inhibiting an herpes simplex virus (HSV) infection, wherein the plant is a: Cornus species; Achillea species; Trifolium species; Trillium species; and/or Plantago species. The present invention also provides plant extracts, active fractions, and compositions kits comprising same.

The present invention provides a method of using a plant extract or active fraction thereof for inhibiting an herpes simplex virus (HSV) infection, wherein the plant is a: Cornus species; Achillea species; Trifolium species; Trillium species; and/or Plantago species. The present invention also provides plant extracts, active fractions, and compositions kits comprising same.